Physician profile
Alessandro Testori
NPI 1326057050
$1,287.32
in general payments reported to CMS, 2019-2025
23 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $383 · 2021: $393 · 2022: $103 · 2023: $34.10 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $177.19 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $156.57 | 2019-2025 | Wainua |
| Lilly USA, LLC | $128.51 | 2020-2025 | Jardiance |
| Alkermes, INC. | $102.59 | 2022 | |
| Abbvie INC. | $97.77 | 2021-2025 | |
| Genzyme Corporation | $89.19 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $56.74 | 2019-2020 | |
| Glaxosmithkline, LLC. | $56.08 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $51.86 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.15 | 2019-2021 | |
| Biocryst US Sales Co., LLC | $39.49 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $34.90 | 2021 | |
| Astellas Pharma US INC | $34.10 | 2023 | Cresemba |
| Biocryst Pharmaceuticals, INC. | $33.57 | 2020 | |
| Kaleo, INC. | $29.19 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.28 | 2025 | |
| Exact Sciences Corporation | $24.97 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $21.42 | 2021 | |
| Globus Medical, INC. | $20.27 | 2025 | Senza |
| Endo Pharmaceuticals INC. | $15.94 | 2020 | |
| Medtronic Minimed, INC. | $15.62 | 2020 | |
| Pharming Healthcare, INC. | $12.12 | 2021 | |
| Optinose US, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alessandro Testori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.